The hypothalamic orexinergic system: Pain and primary headaches

Headache

Volumn 47, Issue 6, 2007, Pages 951-962

  Holland, Philip ^a   Goadsby, Peter J ^a,b,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hypothalamus; Orexin; Primary headache

Indexed keywords

NEUROTRANSMITTER; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; PEPTIDE HORMONE;

AUTONOMIC NERVOUS SYSTEM; BRAIN DYSFUNCTION; BRAIN FUNCTION; CIRCADIAN RHYTHM; CLUSTER HEADACHE; HUMAN; HYPOTHALAMUS; MIGRAINE; NERVE PROJECTION; NEUROANATOMY; NEUROMODULATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIMARY HEADACHE; PRIORITY JOURNAL; REVIEW; SUNCT SYNDROME; TRANSFORMED MIGRAINE; TRIGEMINAL NUCLEUS;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; HEADACHE DISORDERS, PRIMARY; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURAL PATHWAYS; NEUROPEPTIDES; PAIN;

EID: 34250658987     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00842.x     Document Type: Review

References (155)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004 24 (suppl 1 9 160.
2. Ray BS, Wolff HG. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg. 1940 41 : 813 856.
3. Messlinger K, Burstein R. Anatomy of the central nervous system pathways related to head pain. In : Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, Philadelphia : Lippincott Williams & Wilkins 2000 : 55 76.
4. Go JL, Kim PE, Zee CS. The trigeminal nerve. Semin Ultrasound CT MR. 2001 22 (6 502 520.
5. Olesen J, Edvinsson L. Cephalic neurovascular transmitters and receptors. In : Olesen J, Tfelt-Hansen P, Welch KM, eds. The headaches, Philadelphia : Lippincott Williams & Wilkins 2000 : 87 98.
6. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984 16 (2 157 168.
7. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002 346 (4 257 270.
8. Craig AD. Emotional aspects of pain. In : Wall PD, Melzack R, eds. Textbook of Pain, Edinburgh : Churchill Livingston 1994 : 261 274.
9. Kiernan J. The Human Nervous System: An Anatomical View Point, 7th edn. New York : Lippincott - Raven 1998 : 518.
10. Settle M. The hypothalamus. Neonatal Netw. 2000 19 (6 9 14.
11. Giesler J, Glenn J. Evidence of direct nociceptive projections from the spinal cord to the hypothalamus and telencephalon. Semin Neurosci. 1995 7 (4 253 261.
12. Millan MJ. The induction of pain: An integrative review. Prog Neurobiol. 1999 57 (1 1 164.
13. Jiang M, Behbehani MM. Physiological characteristics of the projection pathway from the medial preoptic to the nucleus raphe magnus of the rat and its modulation by the periaqueductal gray. Pain. 2001 94 (2 139 147.
14. Murphy AZ, Rizvi TA, Ennis M, Shipley MT. The organization of preoptic-medullary circuits in the male rat: Evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation. Neuroscience. 1999 91 (3 1103 1116.
15. Lumb BM. Hypothalamic influences on viscero-somatic neurones in the lower thoracic spinal cord of the anaesthetized rat. J Physiol. 1990 424 : 427 444.
16. Carstens E. Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating. Pain. 1986 25 (1 95 107.
17. Carstens E. Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by medial hypothalamic stimulation in the cat. J Neurophysiol. 1982 48 (3 808 822.
18. Culhane ES, Carstens E. Medial hypothalamic stimulation suppresses nociceptive spinal dorsal horn neurons but not the tail-flick reflex in the rat. Brain Res. 1988 438 (1-2 137 144.
19. Carstens E, Fraunhoffer M, Suberg SN. Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by lateral hypothalamic stimulation in the cat. J Neurophysiol. 1983 50 (1 192 204.
20. Holden JE, Naleway E. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. Brain Res. 2001 911 (1 27 36.
21. Miranda-Cardenas Y, Rojas-Piloni G, Martinez-Lorenzana G, et al. Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist. Pain. 2006 122 (1-2 182 189.
22. Workman BJ, Lumb BM. Inhibitory effects evoked from the anterior hypothalamus are selective for the nociceptive responses of dorsal horn neurons with high- and low-threshold inputs. J Neurophysiol. 1997 77 (5 2831 2835.
23. Yaksh TL. Central pharmacology of nociceptive transmission. In : Wall PD, Melzack R, eds. Textbook of Pain, Edinburgh : Churchill Livingston 1999 : 253 308.
24. Manning BH, Franklin KB. Morphine analgesia in the formalin test: Reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray. Behav Brain Res. 1998 92 (1 97 102.
25. Goadsby PJ. Trigeminal autonomic cephalalgias. Pathophysiology and classification. Rev Neurol (Paris). 2005 161 (6-7 692 695.
26. Goadsby PJ. Trigeminal autonomic cephalalgias: Fancy term or constructive change to the IHS classification? J Neurol Neurosurg Psychiatry. 2005 76 (3 301 305.
27. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997 120 (Pt 1 193 209.
28. Panda S, Hogenesch JB. It's all in the timing: Many clocks, many outputs. J Biol Rhythms. 2004 19 (5 374 387.
29. Davidson AJ, Yamazaki S, Menaker M. SCN: Ringmaster of the circadian circus or conductor of the circadian orchestra? Novartis Found Symp. 2003 253 : 110 121 discussion 121-125, 281-284.
30. Moore RY. Organization and function of a central nervous system circadian oscillator: The suprachiasmatic hypothalamic nucleus. Fed Proc. 1983 42 (11 2783 2789.
31. Buijs RM, Wortel J, Van Heerikhuize JJ, et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999 11 (5 1535 1544.
32. Pringsheim T. Cluster headache: Evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci. 2002 29 (1 33 40.
33. Dodick DW, Eross EJ, Parish JM. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. 2003 43 (3 282 292.
34. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology. 2000 55 (9 1328 1335.
35. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998 352 (9124 275 278.
36. Sprenger T, Boecker H, Tolle TR, et al. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology. 2004 62 (3 516 517.
37. Sprenger T, Valet M, Hammes M, et al. Hypothalamic activation in trigeminal autonomic cephalgia: Functional imaging of an atypical case. Cephalalgia. 2004 24 (9 753 757.
38. May A, Ashburner J, Büchel C, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 1999 5 (7 836 838.
39. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic deep brain stimulation for intractable chronic cluster headache: A 3-year follow-up. Neurol Sci. 2003 24 (suppl 2 S143 S145.
40. Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: First reported series. Neurosurgery. 2003 52 (5 1095 1099 discussion 1099-1101.
41. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 2001 345 (19 1428 1429.
42. Peres MF, Sanchez del Rio M, Seabra ML, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001 71 (6 747 751.
43. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: An electronic diary study. Neurology. 2003 60 (6 935 940.
44. Kelman L. The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs. Headache. 2004 44 (9 865 872.
45. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004 110 (3 675 680.
46. Zurak N. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks. Cephalalgia. 1997 17 (7 723 728.
47. Solomon GD. Circadian rhythms and migraine. Cleve Clin J Med. 1992 59 (3 326 329.
48. Fox AW, Davis RL. Migraine chronobiology. Headache. 1998 38 (6 436 441.
49. MacGregor A. Migraine associated with menstruation. Funct Neurol. 2000 15 (suppl 3 143 153.
50. May A, Bahra A, Buchel C, Turner R, Goadsby PJ. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: Short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol. 1999 46 (5 791 794.
51. Malick A, Jakubowski M, Elmquist JK, Saper CB, Burstein R. A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci U S A. 2001 98 (24 14186 14186.
52. Benjamin L, Levy MJ, Lasalandra MP, et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: A Fos study. Neurobiol Dis. 2004 16 (3 500 505.
53. Sakurai T. Reverse pharmacology of orexin: From an orphan GPCR to integrative physiology. Regul Pept. 2005 126 (1-2 3 10.
54. Sakurai T, et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior (vol 92, pg 573, 1998). Cell. 1998 92 (5 U29 U29.
55. Lee JH, Bang E, Chae KJ, et al. Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. Eur J Biochem. 1999 266 (3 831 839.
56. Soll R, Beck-Sickinger AG. On the synthesis of orexin A: A novel one-step procedure to obtain peptides with two intramolecular disulphide bonds. J Pept Sci. 2000 6 (8 387 397.
57. Okumura T, Takeuchi S, Motomura W, et al. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem Biophys Res Commun. 2001 280 (4 976 981.
58. Darker JG, Porter RA, Eggleston DS, et al. Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor. Bioorg Med Chem Lett. 2001 11 (5 737 740.
59. Dyer CJ, Touchette KJ, Carroll JA, Allee GL, Matteri RL. Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs. Domest Anim Endocrinol. 1999 16 (3 145 148.
60. Shibahara M, Sakurai T, Nambu T, et al. Structure, tissue distribution, and pharmacological characterization of Xenopus orexins. Peptides. 1999 20 (10 1169 1176.
61. Kim HY, Hong E, Kim JI, Lee W. Solution structure of human orexin-A: Regulator of appetite and wakefulness. J Biochem Mol Biol. 2004 37 (5 565 573.
62. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience. 2001 103 (3 777 797.
63. Trivedi P, Yu H, MacNeil DJ, Van Der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998 438 (1-2 71 75.
64. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001 435 (1 6 25.
65. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett. 1999 260 (3 161 164.
66. Cutler DJ, Morris R, Sheridhar V, et al. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides. 1999 20 (12 1455 1470.
67. Date Y, Mondal MS, Matsukura S, Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett. 2000 288 (2 87 90.
68. Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A. 1999 96 (2 748 753.
69. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998 95 (1 322 327.
70. Harrison TA, Chen CT, Dun NJ, Chang JK. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett. 1999 273 (1 17 20.
71. Horvath TL, Diano S, Van Den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J Neurosci. 1999 19 (3 1072 1087.
72. Horvath TL, Peyron C, Diano S, et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol. 1999 415 (2 145 159.
73. Horvath TL, Warden CH, Hajos M, et al. Brain uncoupling protein 2: Uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers. J Neurosci. 1999 19 (23 10417 10427.
74. Mondal MS, Nakazato M, Matsukura S. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models. Neurosci Lett. 1999 273 (1 45 48.
75. Mondal MS, Nakazato M, Date Y, et al. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem Biophys Res Commun. 1999 256 (3 495 499.
76. Van Den Pol AN. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J Neurosc. 1999 19 (8 3171 3182.
77. Foord SM, Bonner TI, Neubig RR, et al. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev. 2005 57 (2 279 288.
78. Lund PE, Shariatmadari R, Uustare A, et al. The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem. 2000 275 (40 30806 30812.
79. Smart D, Jerman JC, Brough SJ, et al. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol. 1999 128 (1 1 3.
80. Ferguson AV, Samson WK. The orexin/hypocretin system: A critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol. 2003 24 (3 141 150.
81. Siegel JM. Hypocretin (orexin): Role in normal behavior and neuropathology. Annu Rev Psychol. 2004 55 : 125 148.
82. Samson WK, Taylor MM, Ferguson AV. Non-sleep effects of hypocretin/orexin. Sleep Med Rev. 2005 9 (4 243 252.
83. Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev. 2005 9 (4 231 241.
84. Bingham S, Davey PT, Babbs AJ, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001 92 (1-2 81 90.
85. Cheng JK, Chou RC, Hwang LL, Chiou LC. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther. 2003 307 (3 1065 1071.
86. Kajiyama S, Kawamoto M, Shiraishi S, et al. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats. Brain Res. 2005 1044 (1 76 86.
87. Yamamoto T, Saito O, Shono K, Aoe T, Chiba T. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett. 2003 347 (3 183 186.
88. Peyron C, Tighe DK, Van Den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998 18 (23 9996 10015.
89. Zhang JH, Sampogna S, Morales FR, Chase MH. Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla. Brain Res. 2004 995 (2 205 217.
90. Backberg M, Hervieu G, Wilson S, Meister B. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: Focus on orexin targets involved in control of food and water intake. Euro J Neuros. 2002 15 (2 315 328.
91. Millan MJ, Przewlocki R, Millan MH, Herz A. Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat. Pharmacol Biochem Behav. 1983 18 (6 901 907.
92. Yamamoto T, Nozaki-Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol. 2002 137 (2 170 176.
93. Suyama H, Kawamoto M, Shiraishi S, et al. Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats. In Vivo. 2004 18 (2 119 123.
94. Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport. 2005 16 (1 5 8.
95. Millan MJ. Descending control of pain. Prog Neurobiol. 2002 66 (6 355 474.
96. Mobarakeh JI, Takahashi K, Sakurada S, et al. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides. 2005 26 (5 767 777.
97. Yamamoto T, Saito O, Shono K, Hirasawa S. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur J Pharmacol. 2003 481 (2-3 175 180.
98. Aldrich MS. Narcolepsy. N Engl J Med. 1990 323 (6 389 394.
99. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 6 (9 991 997.
100. Dahmen N, Querings K, Grun B, Bierbrauer J. Increased frequency of migraine in narcoleptic patients. Neurology. 1999 52 (6 1291 1293.
101. Bigal ME, Lipton RB, Stewart WF. The epidemiology and impact of migraine. Curr Neurol Neurosci Rep. 2004 4 (2 98 104.
102. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults. Psychiatry Res. 1991 37 (1 11 23.
103. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: The global migraine and zolmitriptan evaluation survey. Headache. 2003 43 (1 19 26.
104. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol. 1991 44 (11 1147 1157.
105. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: An epidemiological study. Cephalalgia. 1992 12 (4 221 228 discussion 186.
106. Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: A meta-analysis. J Clin Epidemiol. 1995 48 (2 269 280.
107. Dahmen N, Kasten M, Wieczorek S, et al. Increased frequency of migraine in narcoleptic patients: A confirmatory study. Cephalalgia. 2003 23 (1 14 19.
108. Gobel H, Soyka D. [Migraine and tension headache. New procedures for objective differentiation]. Fortschr Med. 1992 110 (35-36 659 663.
109. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache. 1987 27 (8 416 420.
110. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 1 (7 658 660.
111. Afridi S, Goadsby PJ. New onset migraine with a brain stem cavernous angioma. J Neurol Neurosurg Psychiatry. 2003 74 (5 680 682.
112. Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005 128 (Pt 4 932 939.
113. Datta S. Cellular basis of pontine ponto-geniculo-occipital wave generation and modulation. Cell Mol Neurobiol. 1997 17 (3 341 365.
114. Rainero I, Gallone S, Valfre W, et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology. 2004 63 (7 1286 1288.
115. Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol. 2006 59 (3 535 545.
116. Denuelle M, Fabre N, Payoux P, Chollet F, GG. Brainstem and hypothalamic activation in spontaneous migraine attacks. Cephalalgia. 2004 24 : 775 814.
117. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology. 2001 142 (8 3324 3331.
118. Johren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides. 2002 23 (6 1177 1180.
119. Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci. 2006 24 (10 2825 2833.
120. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005 315 (3 1380 1385.
121. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain. 2004 109 (3 367 378.
122. Buijs RM, Van Eden CG. The integration of stress by the hypothalamus, amygdala and prefrontal cortex: Balance between the autonomic nervous system and the neuroendocrine system. Prog Brain Res. 2000 126 : 117 132.
123. Smart D. Orexins: A new family of neuropeptides. Br J Anaesth. 1999 83 (5 695 697.
124. Overeem S, van Vliet JA, Lammers GJ, et al. The hypothalamus in episodic brain disorders. Lancet Neurol. 2002 1 (7 437 444.
125. Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med. 2007 13 : 150 155. Epub 2007 Jan 28.
126. Cluderay JE, Harrison DC, Hervieu GJ. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept. 2002 104 (1-3 131 144.
127. Liu RJ, Van Den Pol AN, Aghajanian GK. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci. 2002 22 (21 9453 9464.
128. Brown RE, Sergeeva O, Eriksson KS, Haas HL. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology. 2001 40 (3 457 459.
129. Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosc. 2002 22 (20 8850 8859.
130. Bubser M, Fadel JR, Jackson LL, et al. Dopaminergic regulation of orexin neurons. Eur J Neurosci. 2005 21 (11 2993 3001.
131. Hirota K, et al. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol. 2001 134 (7 1461 1466.
132. Ishizuka T, Yamamoto Y, Yamatodani A. The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats. Neuroscience Letters. 2002 323 (2 93 96.
133. Kohlmeier KA, Inoue T, Leonard CS. Hypocretin/Orexin peptide signalling in the ascending arousal system: Elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol. 2004.
134. Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept. 2002 104 (1-3 83 89.
135. Russell SH, Kim MS, Small CJ, et al. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol. 2000 12 (12 1213 1218.
136. Van Den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci. 1998 18 (19 7962 7971.
137. Eriksson KS, Sergeeva OA, Selbach O, Haas HL. Orexin (hypocretin)/ dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur J Neurosci. 2004 19 (5 1278 1284.
138. Raulf F, Perez J, Hoyer D, Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion. 1994 55 (suppl 3 46 53.
139. Schindler M, Humphrey PP, Emson PC. Somatostatin receptors in the central nervous system. Prog Neurobiol. 1996 50 (1 9 47.
140. Beaudet A, Greenspun D, Raelson J, Tannenbaum GS. Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: Relationship to neuroendocrine function. Neuroscience. 1995 65 (2 551 561.
141. Del Fiacco M, Quartu M. Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: Immunohistochemistry, neuronal morphometry and colocalization with substance P. J Chem Neuroanat. 1994 7 (3 171 184.
142. Lazarov N, Chouchkov C. Localization of somatostatin-like immunoreactive fibres in the trigeminal principal sensory nucleus of the cat. Acta Histochem. 1990 89 (1 91 97.
143. Handel M, Schulz S, Stanarius A, et al. Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience. 1999 89 (3 909 926.
144. Schindler M, Holloway S, Hathway G, et al. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res. 1998 798 (1-2 25 35.
145. Chrubasik J, Meynadier J, Scherpereel P, Wunsch E. The effect of epidural somatostatin on postoperative pain. Anesth Analg. 1985 64 (11 1085 1088.
146. Mollenholt P, Rawal N, Gordh T, Jr., Olsson Y. Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots. Anesthesiology. 1994 81 (3 534 542.
147. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004 56 (4 488 494.
148. Kapicioglu S, Gokce E, Kapicioglu Z, Ovali E. Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia. 1997 17 (1 27 30.
149. Murase K, Nedeljkov V, Randic M. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: An intracellular study. Brain Res. 1982 234 (1 170 176.
150. Randic M, Miletic V. Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli. Brain Res. 1978 152 (1 196 202.
151. Chapman V, Dickenson AH. The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides. 1992 23 (3 147 152.
152. Tashev R, Belcheva S, Milenov K, Belcheva I. Antinociceptive effect of somatostatin microinjected into caudate putamen. Peptides. 2001 22 (7 1079 1083.
153. Helmchen C, Fu QG, Sandkuhler J. Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat. Neurosci Lett. 1995 187 (2 137 141.
154. Bereiter DA. Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience. 1997 77 (3 863 174.
155. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus. Pain. 2005 117 (1-2 30 39.